Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease.
Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2025 Apr 01; 20(4):520-528.
PMID: 39970002
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 2025 Feb; 107(2):234-254.
PMID: 39848746
Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney Disease.
Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2025 Apr 01; 20(4):563-572.
PMID: 39874088
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program.
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program. Kidney360. 2025 Jan 01; 6(1):159-166.
PMID: 39560608
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD.
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD. Kidney Int Rep. 2025 Feb; 10(2):447-456.
PMID: 39990913
Building a Physician/Advanced Practice Provider Partnership for Inpatient Dialysis Care.
Building a Physician/Advanced Practice Provider Partnership for Inpatient Dialysis Care. Kidney360. 2024 Dec 01; 5(12):1922-1924.
PMID: 39466362
Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension.
Cardiac Localized Polycystin-2 in the Natriuretic Peptide Signaling Pathway and Hypertension. J Am Soc Nephrol. 2025 Jan 01; 36(1):34-47.
PMID: 39302726
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials. Am J Kidney Dis. 2025 Jan; 85(1):127-130.
PMID: 39154887
In memoriam: George L. Bakris, MD, 1952-2024.
In memoriam: George L. Bakris, MD, 1952-2024. Kidney Int. 2024 Aug 14.
PMID: 39178909
Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers.
Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers. Clin Transl Sci. 2024 May; 17(5):e13816.
PMID: 38747311